eQCM® software Selected by Ricerca to Optimize Compliance and Quality Business Process Automation
Quebec City, July 30, 2008 – Amadeus, a division of Decimal, a company specialized in business solutions and professional services in corporate performance, quality and compliance management today announced that Ricerca Biosciences, LLC, a CRO that delivers robust preclinical contract drug discovery and development services to US biotechnology and pharmaceutical companies, has selected Amadeus’ eQCM® software platform to automate and manage its quality and compliance management program.
Compliant with FDA regulations including GLP and cGMP and meeting AALAC and IACUC requirements, Ricerca needed to meet the ever changing regulatory landscape by efficiently automating its data-driven workflow and critical business processes.
With eQCM®, Ricerca now has a single and robust solution that enables it to electronically create, manage and securely store all content, records, dashboards and advanced reports. eQCM® software will enable Ricerca to handle among others nonconformance, Corrective Action and Preventive Action (CAPA) as well as internal and external audits, customer complaints and document management.
“Amadeus’ software emerged from our selection process as the optimal candidate for meeting our numerous needs’’ said Stephen Rogenthien, Manager of GLP Operations for Ricerca. “In order to support our commitment to high levels of quality and compliance for our clients, it was fundamental for Ricerca to select and purchase a software package that allowed us to meet that commitment’’ he said.
“Building upon renowned strengths, like usability, flexibility, intuitiveness and reliability and extending those characteristics to new functionalities and improvements as our In-Control Process Statistics page or powerful systems tasks, to name a few capabilities, our quality and compliance technology platform significantly increases operational efficiency and performance ’’ said Pierre-François Isabel, Vice-President of Amadeus, a division of Decimal. “We continue to be recognized as a first-class player,’’ he said.
About Ricerca
Ricerca is the only North American CRO to offer the unique IP-INDSM concept to pharmaceutical and biotechnology companies. The site encompasses all discovery and development services required to bring a target or drug candidate to a complete IND submission. The ability to perform both chemistry (medicinal chemistry, process chemistry, cGMP API kilo-lab and pilot plant production, complete analytical) and biology (DMPK, ADME, full toxicology, safety pharmacology, animal efficacy models, bioanalytical) as well as report writing and regulatory services at one site makes Ricerca the provider of choice for virtual, small, and medium-sized pharmaceutical companies seeking a successful IND submission.
About Decimal
DECIMAL is engaged in the design of specialized solutions in the area of corporate performance management. Most notably, the company operates in the areas of budget planning, strategic cost management, profitability analysis, governance and business intelligence. The new division of Decimal, Amadeus, provides quality and regulatory compliance management solutions in life sciences, manufacturing and financial services.
DECIMAL offers a vast array of consulting services and a Research & Development team that has developed a world class software solution in the activity based management and budgeting area (ABM). More information can be found on DECIMAL at www.decimal.ca
- 30 -
For further information:
Isabelle Rivoal
Communications Director
Amadeus, a division of DECIMAL
Phone: +1 (418) 525-0606, ext. 2231
E-mail: isabelle.rivoal@amadeussolutions.com
